{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:30:26Z","timestamp":1792668626475,"version":"4.5.0"},"reference-count":30,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,7,9]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>We report the first dedicated prospective study in HIV-Burkitt lymphoma demonstrating safety and efficacy in a multi-institutional setting. We offer a new therapeutic option by modifying an existing regimen and making it much less toxic.<\/jats:p>","DOI":"10.1182\/blood-2015-01-623900","type":"journal-article","created":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T22:51:18Z","timestamp":1431125478000},"page":"160-166","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":91,"title":["AMC 048: modified CODOX-M\/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma"],"prefix":"10.1182","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3001-4898","authenticated-orcid":false,"given":"Ariela","family":"Noy","sequence":"first","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette Y.","family":"Lee","sequence":"additional","affiliation":[{"name":"University of Arkansas Medical Center, Little Rock, AR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethel","family":"Cesarman","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Ambinder","sequence":"additional","affiliation":[{"name":"Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Baiocchi","sequence":"additional","affiliation":[{"name":"Division of Hematology, Ohio State Medical Center, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Reid","sequence":"additional","affiliation":[{"name":"University of California San Diego, Moores Cancer Center, La Jolla, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Ratner","sequence":"additional","affiliation":[{"name":"Division of Oncology, Washington University School of Medicine, St. Louis, MO; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Wagner-Johnston","sequence":"additional","affiliation":[{"name":"Division of Oncology, Washington University School of Medicine, St. Louis, MO; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"5","key":"2019111903495970700_B1","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/1097-0142(1967)20:5<756::AID-CNCR2820200530>3.0.CO;2-P","article-title":"Long-term remissions following one and two-dose chemotherapy for African lymphoma.","volume":"20","author":"Burkitt","year":"1967","journal-title":"Cancer"},{"issue":"5","key":"2019111903495970700_B2","first-page":"389","article-title":"Burkitt\u2019s lymphoma in adults: a retrospective study of 46 cases.","volume":"34","author":"Ostronoff","year":"1992","journal-title":"Nouv Rev Fr Hematol"},{"issue":"9","key":"2019111903495970700_B3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0753-3322(97)86004-0","article-title":"Treatment of Burkitt\u2019s lymphoma in HIV-positive patients.","volume":"50","author":"Straus","year":"1996","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"2019111903495970700_B4","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1200\/JCO.1998.16.11.3601","article-title":"Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin\u2019s lymphoma: analysis of AIDS Clinical Trials Group protocol 142\u2014low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor.","volume":"16","author":"Straus","year":"1998","journal-title":"J Clin Oncol"},{"issue":"23","key":"2019111903495970700_B5","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199706053362304","article-title":"Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin\u2019s lymphoma associated with human immunodeficiency virus infection.","volume":"336","author":"Kaplan","year":"1997","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111903495970700_B6","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.1996.14.3.925","article-title":"Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen.","volume":"14","author":"Magrath","year":"1996","journal-title":"J Clin Oncol"},{"issue":"8","key":"2019111903495970700_B7","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/annonc\/mdf253","article-title":"An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt\u2019s lymphoma: results of United Kingdom Lymphoma Group LY06 study.","volume":"13","author":"Mead","year":"2002","journal-title":"Ann Oncol"},{"issue":"8","key":"2019111903495970700_B8","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1200\/JCO.1999.17.8.2461","article-title":"Hyper-CVAD program in Burkitt\u2019s-type adult acute lymphoblastic leukemia.","volume":"17","author":"Thomas","year":"1999","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019111903495970700_B9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0950-3536(05)80206-9","article-title":"Therapy of Burkitt and other B-cell acute lymphoblastic leukaemia and lymphoma: experience with the LMB protocols of the SFOP (French Paediatric Oncology Society) in children and adults.","volume":"7","author":"Patte","year":"1994","journal-title":"Baillieres Clin Haematol"},{"issue":"5","key":"2019111903495970700_B10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/ajcp\/103.5.561","article-title":"AIDS-related Burkitt\u2019s lymphoma. Morphologic and immunophenotypic study of biopsy specimens.","volume":"103","author":"Carbone","year":"1995","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"2019111903495970700_B11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1182\/blood.V80.1.8.8","article-title":"Acquired immunodeficiency syndrome-related lymphoma.","volume":"80","author":"Levine","year":"1992","journal-title":"Blood"},{"issue":"8745","key":"2019111903495970700_B12","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0140-6736(91)92513-2","article-title":"AIDS-associated non-Hodgkin lymphoma.","volume":"337","author":"Beral","year":"1991","journal-title":"Lancet"},{"issue":"15","key":"2019111903495970700_B13","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1097\/QAD.0000000000000428","article-title":"Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study.","volume":"28","author":"Gibson","year":"2014","journal-title":"AIDS"},{"issue":"4","key":"2019111903495970700_B14","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/(SICI)1097-0142(19980215)82:4<766::AID-CNCR21>3.0.CO;2-V","article-title":"Burkitt\u2019s lymphoma in adults with and without human immunodeficiency virus infection: a single-institution clinicopathologic study of 75 patients.","volume":"82","author":"Spina","year":"1998","journal-title":"Cancer"},{"issue":"12","key":"2019111903495970700_B15","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1200\/JCO.1998.16.12.3788","article-title":"Burkitt-like lymphomas in AIDS patients: characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin\u2019s lymphomas.","volume":"16","author":"Davi","year":"1998","journal-title":"J Clin Oncol"},{"issue":"9","key":"2019111903495970700_B16","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1200\/JCO.1987.5.9.1322","article-title":"AIDS-related malignant lymphoma: results of prospective treatment trials.","volume":"5","author":"Gill","year":"1987","journal-title":"J Clin Oncol"},{"issue":"33","key":"2019111903495970700_B17","doi-asserted-by":"crossref","first-page":"8477","DOI":"10.1200\/JCO.2005.02.9355","article-title":"Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy.","volume":"23","author":"Lim","year":"2005","journal-title":"J Clin Oncol"},{"issue":"6","key":"2019111903495970700_B18","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/cncr.11628","article-title":"Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate\/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M\/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.","volume":"98","author":"Wang","year":"2003","journal-title":"Cancer"},{"issue":"4","key":"2019111903495970700_B19","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/1042819031000141301","article-title":"Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity.","volume":"45","author":"Lacasce","year":"2004","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"2019111903495970700_B20","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.","volume":"17","author":"Harris","year":"1999","journal-title":"J Clin Oncol"},{"key":"2019111903495970700_B21","article-title":"Practical Nonparametric Statistics.","author":"Conover","year":"2001","edition":"3rd ed"},{"issue":"5","key":"2019111903495970700_B22","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood-2005-04-1437","article-title":"Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.","volume":"106","author":"Kaplan","year":"2005","journal-title":"Blood"},{"issue":"6","key":"2019111903495970700_B23","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/QAD.0b013e3283301578","article-title":"Excellent immunological recovery following CODOX-M\/IVAC, an effective intensive chemotherapy for HIV-associated Burkitt\u2019s lymphoma.","volume":"24","author":"Montoto","year":"2010","journal-title":"AIDS"},{"issue":"7","key":"2019111903495970700_B24","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/cncr.21776","article-title":"Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.","volume":"106","author":"Thomas","year":"2006","journal-title":"Cancer"},{"key":"2019111903495970700_B25","author":"Kaplan"},{"issue":"15","key":"2019111903495970700_B26","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1182\/blood-2009-11-253039","article-title":"The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma.","volume":"115","author":"Dunleavy","year":"2010","journal-title":"Blood"},{"issue":"2","key":"2019111903495970700_B27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/blood-2004-05-1982","article-title":"High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology.","volume":"105","author":"Hegde","year":"2005","journal-title":"Blood"},{"key":"2019111903495970700_B28","author":"Dunleavy"},{"issue":"12","key":"2019111903495970700_B29","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1182\/blood-2002-11-3589","article-title":"Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology.","volume":"101","author":"Little","year":"2003","journal-title":"Blood"},{"issue":"12","key":"2019111903495970700_B30","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/00002030-200108170-00005","article-title":"Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy.","volume":"15","author":"Antinori","year":"2001","journal-title":"AIDS"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/126\/2\/160\/1390043\/160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/126\/2\/160\/1390043\/160.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T03:50:09Z","timestamp":1574135409000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/126\/2\/160\/34480\/AMC-048-modified-CODOXMIVACrituximab-is-safe-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,9]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,7,9]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2015-01-623900","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,9]]}}}